52.50
0.04%
0.02
After Hours:
52.51
0.010
+0.02%
Livanova Plc stock is traded at $52.50, with a volume of 261.93K.
It is up +0.04% in the last 24 hours and down -0.89% over the past month.
See More
Previous Close:
$52.48
Open:
$53
24h Volume:
261.93K
Relative Volume:
0.56
Market Cap:
$2.90B
Revenue:
$1.24B
Net Income/Loss:
$23.68M
P/E Ratio:
1,050.00
EPS:
0.05
Net Cash Flow:
$108.67M
1W Performance:
+2.30%
1M Performance:
-0.89%
6M Performance:
-13.18%
1Y Performance:
+17.00%
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
52.50 | 2.90B | 1.24B | 23.68M | 108.67M | 0.42 |
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-04-24 | Initiated | Goldman | Buy |
Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
Mar-20-24 | Reiterated | Needham | Buy |
Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
Sep-06-23 | Initiated | HSBC Securities | Hold |
Jul-19-23 | Initiated | Robert W. Baird | Neutral |
Apr-14-23 | Initiated | Mizuho | Neutral |
Dec-21-22 | Initiated | Barclays | Equal Weight |
Apr-06-22 | Initiated | Wolfe Research | Outperform |
Feb-24-22 | Upgrade | UBS | Neutral → Buy |
Dec-03-21 | Initiated | Goldman | Buy |
Aug-20-21 | Reiterated | Needham | Buy |
Jul-20-21 | Upgrade | Needham | Hold → Buy |
Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
Jan-05-21 | Downgrade | Needham | Buy → Hold |
Sep-02-20 | Initiated | Robert W. Baird | Outperform |
Jun-26-20 | Reiterated | Needham | Buy |
Oct-30-19 | Reiterated | Needham | Buy |
Feb-28-19 | Reiterated | Needham | Buy |
Nov-28-18 | Initiated | UBS | Neutral |
Aug-02-18 | Reiterated | Needham | Buy |
Jun-08-18 | Initiated | Stifel | Buy |
May-31-18 | Reiterated | Needham | Buy |
Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
LivaNova PLC's (NASDAQ:LIVN) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? - Simply Wall St
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - MSN
Quantbot Technologies LP Buys New Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC's (NASDAQ:LIVN) Stock Has Shown A Decent Performance: Have Financials A Role To Play? - Yahoo Finance
Wall Street Analysts Predict a 37.2% Upside in LivaNova (LIVN): Here's What You Should Know - Yahoo Finance
Implantable Cardioverter Defibrillator Market Size, Trends, - openPR
Perfusion Systems Market Size, Trends, Growth, Opportunities - openPR
Needham retains Buy on Livanova shares, cites impressive track record - Investing.com
Needham & Company LLC Reiterates "Buy" Rating for LivaNova (NASDAQ:LIVN) - MarketBeat
Algert Global LLC Purchases 47,008 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Segall Bryant & Hamill LLC Invests $2.13 Million in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova's SWOT analysis: sleep apnea platform potential drives stock outlook - Investing.com
LivaNova PLC (NASDAQ:LIVN) Shares Sold by Primecap Management Co. CA - MarketBeat
Principal Financial Group Inc. Has $9.01 Million Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Cornercap Investment Counsel Inc. Sells 10,684 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Position Boosted by Victory Capital Management Inc. - MarketBeat
10,067 Shares in LivaNova PLC (NASDAQ:LIVN) Acquired by Entropy Technologies LP - MarketBeat
LivaNova (NASDAQ:LIVN) Cut to "Buy" at StockNews.com - MarketBeat
State of New Jersey Common Pension Fund D Purchases 11,782 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences - sharewise
Medical Implants Market Is Booming Worldwide 2024-2031 | Biotronik, Inc., Livanova Plc, NuVasive - openPR
LivaNova's (LIVN) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
LivaNova PLC (LIVN) SEC Filing Summary - Quartzy
Shareholders Will Be Pleased With The Quality of LivaNova's (NASDAQ:LIVN) Earnings - Yahoo Finance
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St
Vagus Nerve Stimulation (VNS) Market Market Size, Trends, - openPR
LivaNova announces OSPREY clinical study meets safety/efficacy endpoints - TipRanks
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - sharewise
LivaNova reports positive results in sleep apnea trial By Investing.com - Investing.com South Africa
LivaNova reports positive results in sleep apnea trial - Investing.com India
LivaNova plc (LIVN) Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - StreetInsider.com
Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
LivaNova (NASDAQ:LIVN) Upgraded by StockNews.com to Strong-Buy Rating - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
LivaNova (LIVN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
How Much Upside is Left in LivaNova (LIVN)? Wall Street Analysts Think 38.2% - Yahoo Finance
Chest Drainage Catheters Market Driven by Advancements in Medical Devices | LivaNova PLC, Mediplus, - EIN News
Oversold Conditions For LivaNova (LIVN) - Nasdaq
LivaNova (NASDAQ:LIVN) Trading Down 3.9%Should You Sell? - MarketBeat
LivaNova Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Nisa Investment Advisors LLC Lowers Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Is a LivaNova PLC (LIVN) Promising Medical Stock with Growth Potential? - Insider Monkey
Emerald Advisers LLC Purchases 14,302 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Simply Wall St
Earnings Beat: LivaNova PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Where are the Opportunities in (LIVN) - Stock Traders Daily
abrdn plc Purchases 70,618 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova maintains VNS Therapy classification By Investing.com - Investing.com Australia
LivaNova maintains VNS Therapy classification - Investing.com India
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):